These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25788523)

  • 1. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
    Kasembeli AN; Duarte R; Ramsay M; Mosiane P; Dickens C; Dix-Peek T; Limou S; Sezgin E; Nelson GW; Fogo AB; Goetsch S; Kopp JB; Winkler CA; Naicker S
    J Am Soc Nephrol; 2015 Nov; 26(11):2882-90. PubMed ID: 25788523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
    Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
    Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
    Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
    Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
    J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
    Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
    BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma apolipoprotein L1 levels do not correlate with CKD.
    Bruggeman LA; O'Toole JF; Ross MD; Madhavan SM; Smurzynski M; Wu K; Bosch RJ; Gupta S; Pollak MR; Sedor JR; Kalayjian RC
    J Am Soc Nephrol; 2014 Mar; 25(3):634-44. PubMed ID: 24231663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
    Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
    PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOL1 variants associate with increased risk of CKD among African Americans.
    Foster MC; Coresh J; Fornage M; Astor BC; Grams M; Franceschini N; Boerwinkle E; Parekh RS; Kao WH
    J Am Soc Nephrol; 2013 Sep; 24(9):1484-91. PubMed ID: 23766536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOL1 kidney risk alleles: population genetics and disease associations.
    Limou S; Nelson GW; Kopp JB; Winkler CA
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):426-33. PubMed ID: 25168832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
    Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
    Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics: Strong association of APOL1 risk variants with HIV-associated nephropathy in black South Africans.
    Allison SJ
    Nat Rev Nephrol; 2015 Jun; 11(6):318. PubMed ID: 25848879
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
    Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
    Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.
    Ulasi II; Tzur S; Wasser WG; Shemer R; Kruzel E; Feigin E; Ijoma CK; Onodugo OD; Okoye JU; Arodiwe EB; Ifebunandu NA; Chukwuka CJ; Onyedum CC; Ijoma UN; Nna E; Onuigbo M; Rosset S; Skorecki K
    Nephron Clin Pract; 2013; 123(1-2):123-8. PubMed ID: 23860441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
    Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
    Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
    Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
    Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
    Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
    J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations.
    Ko WY; Rajan P; Gomez F; Scheinfeldt L; An P; Winkler CA; Froment A; Nyambo TB; Omar SA; Wambebe C; Ranciaro A; Hirbo JB; Tishkoff SA
    Am J Hum Genet; 2013 Jul; 93(1):54-66. PubMed ID: 23768513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
    Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
    Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
    Anyaegbu EI; Shaw AS; Hruska KA; Jain S
    Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.